Safety and therapeutic effect of insulin detemir in Taiwanese patients with type 2 diabetes mellitus not achieving glycaemic targets with OAD [oral anti-diabetic drug] with/without once-daily NPH [neutral protamine Hagedorn] insulin treatment
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 03 Sep 2007 New trial record.